Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Commentary · 2012 Conference abstract · 2018 Treating Reward Deficiency Syndrome (RDS) with a nutrigenomic dopaminergic brain activator by targeting reward gene polymorphisms utilizing genetic algorithms
Background: Algorithms based on the identification of reward genes polymorphic targets were successfully used to customize Neuro Adaptagen Amino acid Therapy (NAAT) [KB220]1 for the treatment of obesity ... treatment…
Commentary · 5 Jul 2014 Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?
long-term utilization. However, it seems prudent to embrace genetic testing to reveal reward circuitry gene polymorphisms especially those related to dopaminergic pathways as well as opioid receptor
Research article · 28 Jan 2021 Direct, Indirect and Epistatic Associations of Reward System Genes with Heroin Dependence
Objective: Genes encoding molecular pathways of the reward system are implicated in both addiction and impulsivity. A complex interplay of these genes is likely to contribute to the risk ... heroin dependence being…
Conference abstract · 22 Jun 2013 Generational association studies of Dopaminergic genes in Reward Deficiency Syndrome (RDS) subjects
At the present time, the problem of substance abuse among young individuals
Perspective · 29 Jun 2023 Evidence for the Drd2 Gene as a Determinant of Reward Deficiency Syndrome (RDS)
clinical relevance of the Genetic Addiction Risk Severity (GARS) test in identifying risk for reward deficiency behaviors in cohorts from polysubstance and pain clinics, post-surgical bariatrics, and DWI offenders…
Commentary · 27 Nov 2012 Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function ofMolecular Neurobiological Mechanisms
In accord with the new definition of addiction published by American Society
Mini review · 10 Oct 2013 Genospirituality: Our Beliefs, Our Genomes, and Addictions
Addictions to smoking, alcohol, illicit drugs, and certain behaviors like gambling, overeating
Conference abstract · 16 Feb 2023 Evidence based clinical analytics supporting the Genetic Addiction Risk Severity (gars) assessment to early identify probands in Addiction psychiatry
group developed the GARS test consisting of ten genes and eleven SNPs across the finite neurotransmitter pathways representative of the Brain Reward Circuitry DNA hypodopaminergia antecedents to addiction psychiatry8…
Conference abstract · 13 Aug 2013 Reward Deficiency Solution System(RDSS): Changing the landscape of treatment and relapse prevention for all addictions utilizing evidence- based research in humans and animal models
receptor gene (DRD1), dopamine transporter gene (DAT1) and dopamine beta-hydroxylase gene (DBH) polymorphisms in Reward Deficiency Syndrome (RDS) subjects derived from two families. We illustrated the relevance ... DRD1…
Letter · 30 Apr 2014 Genome Wide Sequencing Compared to Candidate Gene Association Studies for Predisposition to Substance Abuse a Subset of Reward Deficiency Syndrome (RDS): Are we throwing the Baby Out with the Bathwater?
very complex disorder known as Reward Deficiency Syndrome (RDS) as an umbrella term for all addictions, future approaches may combine both genome sequencing with gene candidates. Importantly, GWAS/WES generally
Research article · 28 Jun 2017 Hypodopaminergic polygenic risk for polysubstance use.
Twin studies have shown substantial heritability for polysubstance use. Previous research has
Research article · 23 Apr 2013 Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note
during follow-up while taking KB220Z daily. We also genotyped the patient using a reward gene panel including (9 genes 18 alleles): DRD 2,3,4; MOA-A; COMT; DAT1
Conference abstract · 22 Jun 2013 Genetic Addiction Risk Scores (GARS) coupled with the Comprehensive Analysis of Reported Drugs (CARD) provide diagnostic and outcome data supporting the need for dopamine D2 agonist therapy: Proposing a holistic -therapeutic model for Reward Deficiency Syndrome (RDS)
Numerous studies have revealed an association between dopaminergic gene polymorphisms and several reward dependent thoughts and behaviors including addictive, obsessive, compulsive and impulsive tendencies. These…
Conference abstract · 19 Nov 2012 Coupling the Genetic Addiction Risk Score (GARS),™ Comprehensive Analysis of Reported Drugs (CARD)™ and KB220Z™ showing reward circuitry activation of dopaminergic pathways in Reward Deficiency Syndrome (RDS): A paradigm
ethnic populations (Caucasian & Chinese) our laboratory using a modified GARS? studied six polymorphic risk genes (DRD2=A1; SLC6A3 (DAT) =10R; DRD4=3R or 7R; 5HTTlRP ... eastern states. We used fMRI and qEEG to evaluate…
Other · 5 May 2021 Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS) ; Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms
In accord with the new definition of addiction published by American Society
Conference abstract · 12 Sep 2016 Application of Transcriptomics on study of biological effects of magnetic field exposure
disease. Transcriptomic analysis, which could to some extent reflect the gene expression alteration under EMF exposure, is rewarding to much deeper understanding on molecular mechanism of living organism sensing
Review article · 2012 Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry
Research article · 4 May 2021 Genetic Variability for Yield and Yield Related Traits in Orange-Fleshed Sweetpotato Genotypes Evaluated at Hawassa, Ethiopia
ground fresh weight, implying that, these characters are governed by additive gene action and selection would be rewarding for the further improvement of such traits
Conference abstract · 6 Jan 2014 Dietary fat preference and adolescent obesity: Genes, environments and possible brain mechanisms
brain-reward system that promote preference for fat and that may in part develop through the combination of genetic and epigenetic variations in the opioid receptor mu 1 gene ( OPRM1 ... preference for fat, an effect…
Review article · 2011 Neuro-Genetics of Reward Deficiency Syndrome (Rds) as the Root Cause of
Conference abstract · 15 Jul 2013 Genetic markers predicting treatment resistant depression
symptom relief was used. Our analysis identified 27 SNPs in 12 genes within muscarinic, nicotinic, adrenergic, serotonergic, dopaminergic, reward and signal transduction pathways. A haplotype analysis indicates that…
Research article · 1 Oct 2016 Accumulation of Highly Stable ΔFosB-Isoforms and Its Targets inside the Reward System of Chronic Drug Abusers - A Source of Dependence-Memory and High Relapse Rate?
sites in the promoter regions of many neural genes. To date, several downstream target genes for ΔFosB have been identified being involved in molecular pathways concerning addictive behavior, memory ... structure close…

